Viewing Study NCT02202993


Ignite Creation Date: 2025-12-25 @ 12:59 AM
Ignite Modification Date: 2026-05-16 @ 2:03 AM
Study NCT ID: NCT02202993
Status: COMPLETED
Last Update Posted: 2019-07-24
First Post: 2014-07-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM
Sponsor: Cavion, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioblastoma Multiforme (GBM) View
Keywords: